Clinical and economic impact of a digital, remotely-delivered intensive behavioral counseling program on medicare beneficiariesat risk for diabetes and cardiovascular disease

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Chen, Fang ^a   Su, Wenqing ^a   Becker, Shawn H ^b   Payne, Mike ^c   Sweet, Cynthia M Castro ^c   Peters, Anne L ^d   Dall, Timothy M ^a  

^a FEKETE ASSOCIATES INC   (United States)

^b Silvercat Advisors   (United States)

^c Omada Health   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DIABETES MELLITUS; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH ECONOMICS; HEALTH PROGRAM; HEALTH STATUS; HEART DISEASE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INTENSIVE BEHAVIORAL COUNSELING; MAJOR CLINICAL STUDY; MALE; MEDICARE; OBESITY; OUTCOME ASSESSMENT; PATIENT COUNSELING; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SIMULATION; TELEMEDICINE; TREATMENT RESPONSE; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; CARDIOVASCULAR DISEASES; COUNSELING; DIABETES MELLITUS, TYPE 2; ECONOMICS; MARKOV CHAIN; PROCEDURES; TELECONSULTATION; THEORETICAL MODEL; UNITED STATES; VERY ELDERLY; WEIGHT LOSS PROGRAM;

ANTIDIABETIC AGENT;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; COUNSELING; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MARKOV CHAINS; MEDICARE; MODELS, THEORETICAL; REMOTE CONSULTATION; RISK FACTORS; UNITED STATES; WEIGHT REDUCTION PROGRAMS;

EID: 84991281759     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0163627     Document Type: Article

References (40)

1. Diabetes Prevention Program Research Group (2015) Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol 3: 866-875. S2213-8587 (15)00291-0 [pii];doi: 10.1016/S2213-8587(15)00291-0 PMID: 26377054
2. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, et al., (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374:1677-1686. S0140-6736(09)61457-4 [pii];doi: 10.1016/S0140-6736(09)61457-4 PMID: 19878986
3. LeFevre ML (2014) Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 161: 587-593. PMID: 25155419 [pii];doi: 10. 7326/M14-1796
4. Ratner R, Goldberg R, Haffner S, Marcovina S, Orchard T, Fowler S, et al., (2005) Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 28: 888-894. 28/4/888 [pii]. PMID: 15793191
5. Siu AL (2015) Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. [pii];doi: 10.7326/M15-2345
6. Sumamo E, Ha C, Korownyk C, Vandermeer B, Dryden DM (2011) Lifestyle Interventions for Four Conditions: Type 2 Diabetes, Metabolic Syndrome, Breast Cancer, and Prostate Cancer. Available: http://www.cms.gov/Medicare/Coverage/DeterminationProcess/Downloads/id82TA.pdf. PMID: 25473696
7. McGill HC Jr., McMahan CA (1998) Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Am J Cardiol 82: 30T-36T. PMID: 9860371
8. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-1847. doi: 10.1161/01.CIR.97. 18.1837 PMID: 9603539
9. Felix HC, West DS (2013) Effectiveness of weight loss interventions for obese older adults. Am J Health Promot 27:191-199. doi: 10.4278/ajhp.110617-LIT-259 PMID: 23286596
10. Kitzman DW, Brubaker P, Morgan T (2016) Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: A randomized clinical trial. Jama 315: 36-46. doi: 10.1001/jama.2015.17346 PMID: 26746456
11. Centers for Disease Control and Prevention (2014) National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Available: http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf.
12. Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, Bibbins-Domingo K (2011) The impact of the aging population on coronary heart disease in the United States. Am J Med 124: 827-833. S0002-9343(11)00295-6 [pii];doi: 10.1016/j.amjmed.2011.04.010 PMID: 21722862
13. Sepah SC, Jiang L, Peters AL (2015) Long-term outcomes of a Web-based diabetes prevention program: 2-year results of a single-arm longitudinal study. J Med Internet Res 17: e92. v17i4e92 [pii];doi: 10.2196/jmir.4052 PMID: 25863515
14. Su W, Chen F, Dall TM, Iacobucci W, Perreault L (2016) Return on Investment for Digital Behavioral Counseling in Patients With Prediabetes and Cardiovascular Disease. Prev Chronic Dis 13: E13. doi: 10.5888/pcd13.150357; E13 [pii]. PMID: 26820045
15. Sepah SC, Jiang L, Peters AL (2014) Translating the Diabetes Prevention Program into an Online Social Network: Validation against CDC Standards. Diabetes Educ 40: 435-443.0145721714531339 [pii];doi: 10.1177/0145721714531339 PMID: 24723130
16. Moin T, Ertl K, Schneider J, Vasti E, Makki F, Richardson C, et al., (2015) Women veterans' experience with a web-based diabetes prevention program: a qualitative study to inform future practice. J Med Internet Res 17: e127. v17i5e127 [pii];doi: 10.2196/jmir.4332 PMID: 26006697
17. Centers for Disease Control and Prevention (CDC) (2015) Centers for Disease Control and Prevention Diabetes Prevention Recognition Program: Standards and Operating Procedures. Available: http://www.cdc.gov/diabetes/prevention/pdf/dprp-standards.pdf.
18. Su W, Huang J, Chen F, Iacobucci W, Mocarski M, Dall TM, et al., (2015) Modeling the clinical and economic implications of obesity using microsimulation. J Med Econ 18: 886-897. doi: 10.3111/13696998.2015.1058805 PMID: 26057567
19. Dall TM, Storm MV, Semilla AP, Wintfeld N, O'Grady M, Narayan KM (2015) Value of lifestyle intervention to prevent diabetes and sequelae. Am J Prev Med 48: 271-280. S0749-3797(14)00580-7 [pii];doi: 10.1016/j.amepre.2014.10.003 PMID: 25498548
20. Semilla AP, Chen F, Dall TM (2015) Reductions in mortality among Medicare beneficiaries following the implementation of Medicare Part D. Am J Manag Care 21: s165-s171. 86231 [pii]. PMID: 26295437
21. Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, et al., (2011) Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet 377:1341-1352. S0140-6736(11)60205-5 [pii];doi: 10.1016/S0140-6736(11)60205-5 PMID: 21481449
22. Heianza Y, Arase Y, Fujihara K, Hsieh SD, Saito K, Tsuji H, et al., (2012) Longitudinal trajectories of HbA1c and fasting plasma glucose levels during the development of type 2 diabetes: the Toranomon Hospital Health Management Center Study 7 (TOPICS 7). Diabetes Care 35:1050-1052. dc11-1793 [pii];doi: 10.2337/dc11-1793 PMID: 22456865
23. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM (2003) Influence of weight reduction on blood pressure a meta-analysis of randomized controlled trials. Hypertension 42: 878-884. doi: 10.1161/01. HYP.0000094221.86888.AE PMID: 12975389
24. Wilson PW, Anderson KM, Harri T, Kannel WB, Castelli WP (1994) Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. Journal of gerontology 49: M252-M257. doi: 10.1093/geronj/49.6.M252 PMID: 7963277
25. Wing RR (2010) Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 170:1566-1575.170/17/1566 [pii];doi: 10.1001/archinternmed.2010.334 PMID: 20876408
26. Clarke PM, Gray AM, Briggs A, Farmer AJ, Fenn P, Stevens RJ, et al., (2004) A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 47:1747-1759. doi: 10.1007/s00125-004-1527-z PMID: 15517152
27. Anderson KM, Odell PM, Wilson PW, Kannel WB (1991) Cardiovascular disease risk profiles. American heart journal 121: 293-298. doi: 10.1016/0002-8703(91)90861-B PMID: 1985385
28. Nichols GA, Reinier K, Chugh SS (2009) Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes care 32:1851-1856. doi: 10.2337/dc09-0939 PMID: 19794003
29. Hippisley-Cox J, Coupland C (2010) Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney-Scores. BMC family practice 11: 49. doi: 10.1186/1471-2296-11-49 PMID: 20565929
30. Kannel WB, Wolf PA, Benjamin EJ, Levy D (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. The American journal of cardiology 82: 2N-9N. PMID: 9809895
31. Kannel WB WPGRJ (1987) The Framingham Study: An Epidemiological Intervention of Cardiovascular Diseases: Section 34: Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death Using Pooled Repeated Biennial Measurements: Framingham Heart Study 30 Year Followup.
32. Wilson PW, Bozeman SR, Burton TM, Hoaglin DC, Ben-Joseph R, Pashos CL (2008) Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation 118:124-130. doi: 10.1161/CIRCULATIONAHA.108.772962 PMID: 18591432
33. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88:107-115. doi: 10.1161/01.CIR.88.1. 107 PMID: 8319323
34. Dagostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al., (2008) General car-diovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 117: 743-753.doi: 10.1161/CIRCULATIONAHA.107.699579 PMID: 18212285
35. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88:107-115. doi: 10.1161/01.CIR.88.1. 107 PMID: 8319323
36. National Cancer Institute (2011) Annualized Mean Net Costs of Care. Available: https://costprojections.cancer.gov/annual.costs.html.
37. Faes C, Molenberghs G, Hens N, Muller A, Goossens H, Coenen S (2011) Analysing the composition of outpatient antibiotic use: a tutorial on compositional data analysis. J Antimicrob Chemother 66 Suppl 6: vi89-vi94. dkr461 [pii];doi: 10.1093/jac/dkr461 PMID: 22096070
38. Kaiser Family Foundation (2014) How Much Is Enough? Out-of-Pocket Spending Among Medicare Beneficiaries: A Chartbook. Available: http://files.kff.org/attachment/how-much-is-enough-out-of-pocket-spending-among-medicare-beneficiaries-a-chartbook-report
39. Congressional Budget Office (2015) March 2015 Medicare baseline. Available: https://www.cbo.gov/sites/default/files/51302-2015-03-Medicare.pdf
40. Thorpe KE, Yang Z, Long KM, Garvey WT (2013) The impact of weight loss among seniors on Medicare spending. Health Econ Rev 3: 7. 2191-1991-3-7 [pii];doi: 10.1186/2191-1991-3-7 PMID: 23514437